Offerings // Journey Medical Corp

DERM offering history

Every offering-related filing in Journey Medical Corp’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 229 filings back to Jul 22, 2021.

Last executed offering

Nov 12, 2021

424B5 — priced deal (shares or notes)

Last registration (announced)

Jan 15, 2026

S-3 — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Jan 23, 2026	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jan 23, 2026	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jan 21, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jan 15, 2026	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Aug 28, 2025	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Feb 17, 2023	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Feb 17, 2023	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jan 26, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 30, 2022	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Nov 12, 2021	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 10, 2021	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Nov 10, 2021	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Nov 10, 2021	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Nov 10, 2021	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Nov 8, 2021	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Oct 22, 2021	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet

DERM offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full DERM workspace →

DERM offering FAQ

When did DERM last execute an offering?

Per SEC filings, Journey Medical Corp's most recent priced offering document is a 424B5 filed 2021-11-12. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did DERM last announce or register an offering?

The most recent registration is a S-3 filed 2026-01-15. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.